GGrantIndex
Sort

64,565 grants matching drug discovery

An integrative omics approach to investigate gene-environment interaction in colorectal cancer risk

$881,894
Ulrike Peters · Fred Hutchinson Cancer Center · R01 · FY2025 · CA

Pharmacology and drug development core

$881,834
Diane Heck · Rbhs-Robert Wood Johnson Medical School · U54 · FY2014 · AR

Tackling Undruggable Cancer Targets using Chemoproteomic Platforms

$881,818
Daniel Nomura · University Of California Berkeley · R35 · FY2024 · CA

Collaborative Research: MFB: Ultra-Fast Development of Portable Small Molecule Sensor-Actuators

$881,704
Tim Whitehead · University Of Colorado At Boulder · · FY2021 · MPS

HLS-Cardiac Safety AI Trained Human Heart and Micro Heart Model

$881,652
Tetsuro Wakatsuki · Invivosciences, Inc. · R44 · FY2019 · HL

Biomarker discovery in colon cancer through next-generation metabolomics

$881,647
Ethan Stancliffe · Panome Bio Inc · R44 · FY2025 · CA

Discovery and development of apoE4 correctors for the treatment of Alzheimer's disease

$881,443
Michael Jackson · Sanford Burnham Prebys Medical Discovery Institute · R56 · FY2024 · AG

Closing the Gaps on Buruli Ulcer Diagnosis, Treatment, and Prevention

$881,258
Eric L Nuermberger · Johns Hopkins University · R01 · FY2018 · AI

Development of small molecule therapeutics for mitigating opioid withdrawal syndrome

$880,957
Sid Ahmed Labed · Evodenovo, Inc. · R44 · FY2024 · DA

Inhibition Of Renal Injury

$880,914
Robert A Star · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2017 · DK

Developing a novel class of peptide antibiotics targeting carbapenem-resistant Gram-negative organisms

$880,743
Yuanpu Peter Di · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · AI

Genetic Epidemiology of Complex Traits

$880,653
Joan E. Bailey-Wilson · National Human Genome Research Institute · ZIA · FY2011 · HG

Discovery of Molecules to disrupt the outer membrane of Gram-negative pathogens

$880,606
Daniel E Kahne · Harvard Medical School · U19 · FY2017 · AI

Mining Actinobacterial Genomes for Natural Product Discovery and Biosynthesis

$880,587
Ben Shen · University Of Florida · R35 · FY2024 · GM

Growth Factor Imaging

$880,575
Peter L. Choyke · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA

Modeling Type II Diabetes and Lipodystrophy Using Patient-Specific iPS Cells

$880,560
Haiming Cao · National Heart, Lung, And Blood Institute · ZIA · FY2012 · HL

Administrative and Data Management Core

$880,446
Tracy L Young-Pearse · Brigham And Women'S Hospital · U54 · FY2025 · AG

Systems Biology based Proteogenomic Translator for Cancer Marker Discovery towards Precision Medicine

$880,383
Pei Wang · Icahn School Of Medicine At Mount Sinai · U24 · FY2019 · CA

Development of Mu Agonist Delta Antagonist Opioids as Analgesics for Chronic Pain

$880,230
Corinne Elizabeth Augelli-Szafran · Southern Research Institute · R01 · FY2019 · DA

Development and Testing of New Computational Methods for Ligand Discovery and Mechanism

$880,204
Brian K. Shoichet · University Of California, San Francisco · R35 · FY2019 · GM

TAS::75 0872::TAS SBIR PHASE II: VALA SCIENCES, TOPIC #44, DEVELOPMENT OF CELL-B

$880,128
Emily Arsenault · Vala Sciences, Inc. · N44 · FY2011 · HL

"Discovery and Development of Anti-Diabetic Drugs."

$880,003
Gerard M Housey · Housey Pharmaceutical Research Lab · R44 · FY2013 · DK

HIV-CRISPR: A novel approach to the comprehensive discovery of HIV latency factors

$880,000
Michael Emerman · Fred Hutchinson Cancer Center · DP1 · FY2023 · DA

HIV-CRISPR: A novel approach to the comprehensive discovery of HIV latency factors

$880,000
Michael Emerman · Fred Hutchinson Cancer Center · DP1 · FY2022 · DA

New Catalytic Reactions for Enhanced Synthetic Efficiency

$880,000
Barry M Trost · Stanford University · · FY2014 · MPS